Biomarkers, low-dose carcinogenesis and dietary exposures

European Journal of Cancer Prevention

Volumn 6, Issue 2, 1997, Pages 147-151

  Vineis, P ^a  

^a Unit of Cancer Epidemiology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

ARTICLE; CANCER; CANCER SUSCEPTIBILITY; CARCINOGENESIS; DIET; HUMAN; OCCUPATIONAL CANCER; PRIORITY JOURNAL; SMOKING;

ANIMALS; BIOLOGICAL MARKERS; CARCINOGENS; DIAGNOSIS, DIFFERENTIAL; DIET; DISEASE SUSCEPTIBILITY; ENVIRONMENTAL EXPOSURE; HUMANS; INCIDENCE; NEOPLASMS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0030742727     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bogen KT (1994). Cancer potencies of heterocyclic amines found in cooked foods. Fed Chem Toxic 32: 505-15.
2. Butler MA, Lang NP, Young JF et al (1992). Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 2: 116-27.
3. Caporaso N, Landi MT, Vineis P (1991). Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epdiemiologic evidence. Pharmacogenetics 1: 4-19.
4. Cartwright R, Ahmad RA, Barham-Hall D et al (1982). Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 2: 842-5.
5. Felton JS, Knize MG (1991). Occurrence, identification and bacterial mutagenicity of heterocyclic amines in cooked food. Mutation Res 259: 205-17.
6. IARC Working Group (1993). Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Volume 56. IARC, Lyon, pp. 229-42.
7. Ilett KF, David BM, Dethon P, Castelden WM, Kwa R (1987). Acetylation phenotype in colorectal carcinoma. Cancer Res 47: 1466-9.
8. Kato S, Bowman ED, Harrington AM, Blomeke B, Shields PG (1995). Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst 87: 902-7.
9. Kelsey KT, Wiencke JK, Spitz MR (1994). A race-specific gentic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans. Carcinogenesis 15: 1121-4.
10. Ladero JM, Gonzalez JF, Benitez J et al (1991). Acetylation polymorphism in human colorectal carcinoma. Cancer Res 51: 2098-100.
11. Lang NP, Chu DZJ, Hunter CF et al (1986). Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg 121: 1259-61.
12. Lang NP, Butler MA, Massengill J, Lawson M, Kadlubar FF (1994). Rapid metabollic phenotypes for acetyltransferase and cytochrome P450 1A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev 3: 675-82.
13. Nakachi K, Imai K, Hayashi S et al (1993). Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53: 2994-9.
14. Oda Y, Tanaka M, Nakanishi I (1994). Relation between the occurrence of K-ras gene point mutations and genotypes of polymorphic N-acetyltransferase in human colorectal carcinomas. Carcinogenesis 15: 1365-9.
15. Ohgaki H, Kusama K, Matsukura N et al (1984). Carcinogenicity in mice of a mutagenic compounds, 2-amino-3-methylimidazo (4,5-f) quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis 5: 921-4.
16. Ohgaki H, Hasegawa H, Suenaga M et al (1986). Induction of hepatocellular carcinoma and highly metastatic squamous cell carcinomas in the forestomach of mice by feeding 2-amino-3,4-dimethylimidazo (4,5-f) quinoline. Carcinogenesis 7: 1889-93.
17. Pariza M W, Aeschbacher HU, Felton JS, Sato S (1990). Mutagens and Carcinogens in the Diet. Wiley-Liss, New York.
18. Pfau W, Brockstedt U, Marquardt H (1994). HPLC analysis of P32-labelled DNA adducts formed by polycyclic aromatic hydrocarbons, polycyclic aromatic amines or heterocyclic aromatic amines. Proceedings of Risk Assessement in Environmental Carcinogenesis, Whistler, 17-22 January.
19. Pott F, Heinrich U (1990). Relative significance of different hydrocarbons for the carcinogenic potency of emissions from various incomplete combustion processes. In Complex Mixtures and Cancer Risk (eds Vainio H, Sorsa M, McMichael AJ); IARC Scientific Publication No. 104, IARC, Lyon.
20. Probst-Hensch NM, Haile RW, Ingles SA et al (1995). Acetylation polymorphism and prevalence of colorectal carcinoma. Cancer Res 55: 2017-20.
21. Roberts-Thomson IC, Ryan P, Khoo KK et al (1997). Diet acetylator phenotype and risk of colorectal neoplasia. Lancet (in press).
22. Shibuta K, Nakashima T, Abe M et al (1994). Molecular genotyping for N-acetylation polymorphism in Japanese patients with colorectal cancer. Cancer 74: 3108-112.
23. Shields PG, Caporaso NE, Falk RT et al (1993). Lung cancer, race and a CYP1A1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev 2: 481-5.
24. Sugimura H, Suzuki I, Shigueaki Haqmada G et al (1994). Cytochrome P-4501A1 genotype in lung cancer patients and controls in Rio de Janeiro, Brazil. Cancer Epidemiol Biomarkers Prev 3: 145-8.
25. Taioli E, Crofts F, Trachman J et al (1995). A specific African-American CYP1A11 polymorphism is associated with adenocarcinoma of the lung. Cancer Res 55: 472-3.
26. Turesky RJ, Lang NP, Butler MA et al (1991). Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 12: 1839-45.
27. Ushiyama H, Wakabayashi K, Hirose M et al (1991). Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating a normal diet, but not in patients receiving parenteral alimentation. Carcinogenesis 12: 1417-22.
28. Vineis P, Bartsch H, Caporaso N et al (1994). Genetically based N-acetylatransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 369: 154-6.